

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.71350900 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.71350900 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.53734800 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.53734800 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.91002903 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.56295922 |
| 7 | glycine metabolic process (GO:0006544) | 5.24637563 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.19719781 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.19719781 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.19719781 |
| 11 | serine family amino acid biosynthetic process (GO:0009070) | 5.19248330 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.15643297 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.04985266 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.04270222 |
| 15 | serine family amino acid catabolic process (GO:0009071) | 5.02754397 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.01078105 |
| 17 | cysteine metabolic process (GO:0006534) | 4.99411068 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.82660357 |
| 19 | serine family amino acid metabolic process (GO:0009069) | 4.75657219 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 4.70494787 |
| 21 | urea cycle (GO:0000050) | 4.65968785 |
| 22 | urea metabolic process (GO:0019627) | 4.65968785 |
| 23 | L-serine metabolic process (GO:0006563) | 4.60133907 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.56624760 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.48767029 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 4.43327087 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.39015809 |
| 28 | homocysteine metabolic process (GO:0050667) | 4.38949257 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.37114366 |
| 30 | establishment of integrated proviral latency (GO:0075713) | 4.34143188 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.33041848 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.32288240 |
| 33 | complement activation, alternative pathway (GO:0006957) | 4.29249449 |
| 34 | bile acid metabolic process (GO:0008206) | 4.28751094 |
| 35 | alpha-amino acid catabolic process (GO:1901606) | 4.25912370 |
| 36 | imidazole-containing compound metabolic process (GO:0052803) | 4.16966231 |
| 37 | lysine metabolic process (GO:0006553) | 4.15827018 |
| 38 | lysine catabolic process (GO:0006554) | 4.15827018 |
| 39 | regulation of complement activation (GO:0030449) | 4.09821259 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.09584448 |
| 41 | protein carboxylation (GO:0018214) | 4.07552709 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.07552709 |
| 43 | * aldehyde catabolic process (GO:0046185) | 4.07041604 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 4.04703559 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.93889941 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 3.93590732 |
| 47 | chromatin remodeling at centromere (GO:0031055) | 3.87024197 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 3.82184349 |
| 49 | coenzyme catabolic process (GO:0009109) | 3.81084395 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 3.75812195 |
| 51 | CENP-A containing nucleosome assembly (GO:0034080) | 3.73685714 |
| 52 | amine catabolic process (GO:0009310) | 3.73204741 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 3.73204741 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 3.72856138 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.70161980 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 3.69528122 |
| 57 | negative regulation of sterol transport (GO:0032372) | 3.69528122 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.67908588 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.67908588 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.67676631 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.67676631 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.67676631 |
| 63 | cellular glucuronidation (GO:0052695) | 3.64912553 |
| 64 | arginine metabolic process (GO:0006525) | 3.61937704 |
| 65 | paraxial mesoderm development (GO:0048339) | 3.60147328 |
| 66 | * ethanol oxidation (GO:0006069) | 3.54916859 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 3.52219655 |
| 68 | one-carbon metabolic process (GO:0006730) | 3.52216871 |
| 69 | bile acid and bile salt transport (GO:0015721) | 3.51589759 |
| 70 | ketone body metabolic process (GO:1902224) | 3.50869919 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.49500894 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.45208202 |
| 73 | carboxylic acid catabolic process (GO:0046395) | 3.42889324 |
| 74 | organic acid catabolic process (GO:0016054) | 3.42889324 |
| 75 | tetrahydrofolate metabolic process (GO:0046653) | 3.42287584 |
| 76 | glutamate metabolic process (GO:0006536) | 3.38538489 |
| 77 | cofactor catabolic process (GO:0051187) | 3.36641408 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 3.35765914 |
| 79 | uronic acid metabolic process (GO:0006063) | 3.34061104 |
| 80 | glucuronate metabolic process (GO:0019585) | 3.34061104 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.31093964 |
| 82 | heme transport (GO:0015886) | 3.26687170 |
| 83 | mitotic metaphase plate congression (GO:0007080) | 3.26658087 |
| 84 | phospholipid efflux (GO:0033700) | 3.24256192 |
| 85 | drug catabolic process (GO:0042737) | 3.21785155 |
| 86 | protein localization to kinetochore (GO:0034501) | 3.20751940 |
| 87 | blood coagulation, intrinsic pathway (GO:0007597) | 3.20213801 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.20196438 |
| 89 | branched-chain amino acid catabolic process (GO:0009083) | 3.19723092 |
| 90 | fibrinolysis (GO:0042730) | 3.18908791 |
| 91 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.17880296 |
| 92 | proteasome assembly (GO:0043248) | 3.15438898 |
| 93 | establishment of viral latency (GO:0019043) | 3.14675279 |
| 94 | drug metabolic process (GO:0017144) | 3.14168391 |
| 95 | urate metabolic process (GO:0046415) | 3.13401324 |
| 96 | histone exchange (GO:0043486) | 3.12457292 |
| 97 | folic acid metabolic process (GO:0046655) | 3.11236208 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.09297890 |
| 99 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.09262179 |
| 100 | DNA replication-independent nucleosome organization (GO:0034724) | 3.09262179 |
| 101 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.08247064 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.08247064 |
| 103 | sulfur amino acid metabolic process (GO:0000096) | 3.06882101 |
| 104 | carnitine metabolic process (GO:0009437) | 3.06242435 |
| 105 | cholesterol efflux (GO:0033344) | 3.05140376 |
| 106 | NAD biosynthetic process (GO:0009435) | 3.04254862 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.03419973 |
| 108 | * response to nitrosative stress (GO:0051409) | 3.03139685 |
| 109 | complement activation, classical pathway (GO:0006958) | 3.02321195 |
| 110 | sulfur amino acid biosynthetic process (GO:0000097) | 3.02042959 |
| 111 | DNA ligation (GO:0006266) | 3.01675466 |
| 112 | IMP biosynthetic process (GO:0006188) | 3.01256404 |
| 113 | fatty acid beta-oxidation (GO:0006635) | 3.01219810 |
| 114 | purine nucleobase biosynthetic process (GO:0009113) | 2.99717665 |
| 115 | DNA replication checkpoint (GO:0000076) | 2.98541817 |
| 116 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.98498917 |
| 117 | DNA double-strand break processing (GO:0000729) | 2.97698622 |
| 118 | metaphase plate congression (GO:0051310) | 2.93214035 |
| 119 | DNA strand elongation (GO:0022616) | 2.85523607 |
| 120 | ribosome assembly (GO:0042255) | 2.83629774 |
| 121 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.82206013 |
| 122 | DNA unwinding involved in DNA replication (GO:0006268) | 2.81185798 |
| 123 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.77636133 |
| 124 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.77636133 |
| 125 | negative regulation of sister chromatid segregation (GO:0033046) | 2.77636133 |
| 126 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.77636133 |
| 127 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.77636133 |
| 128 | DNA damage response, detection of DNA damage (GO:0042769) | 2.77239141 |
| 129 | heterochromatin organization (GO:0070828) | 2.77224755 |
| 130 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76058175 |
| 131 | spindle checkpoint (GO:0031577) | 2.75253868 |
| 132 | mitotic spindle checkpoint (GO:0071174) | 2.72348938 |
| 133 | regulation of helicase activity (GO:0051095) | 2.71761667 |
| 134 | negative regulation of chromosome segregation (GO:0051985) | 2.71483799 |
| 135 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.70622897 |
| 136 | non-recombinational repair (GO:0000726) | 2.70622897 |
| 137 | nucleobase biosynthetic process (GO:0046112) | 2.70247917 |
| 138 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.69926376 |
| 139 | IMP metabolic process (GO:0046040) | 2.68797437 |
| 140 | kinetochore organization (GO:0051383) | 2.65794017 |
| 141 | cullin deneddylation (GO:0010388) | 2.64885373 |
| 142 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.64845783 |
| 143 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.64845783 |
| 144 | anterior/posterior axis specification, embryo (GO:0008595) | 2.63653745 |
| 145 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.63118459 |
| 146 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.61068500 |
| 147 | negative regulation of ligase activity (GO:0051352) | 2.61068500 |
| 148 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.60301964 |
| 149 | regulation of centriole replication (GO:0046599) | 2.59083161 |
| 150 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.58726204 |
| 151 | ribosomal large subunit biogenesis (GO:0042273) | 2.58192893 |
| 152 | mitotic sister chromatid segregation (GO:0000070) | 2.57120134 |
| 153 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.56926923 |
| 154 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.56926923 |
| 155 | ventricular cardiac muscle cell development (GO:0055015) | 2.56695860 |
| 156 | protein localization to chromosome, centromeric region (GO:0071459) | 2.54962141 |
| 157 | mitotic recombination (GO:0006312) | 2.54786542 |
| 158 | sister chromatid segregation (GO:0000819) | 2.54626466 |
| 159 | formation of translation preinitiation complex (GO:0001731) | 2.52427428 |
| 160 | cholesterol biosynthetic process (GO:0006695) | 2.52376903 |
| 161 | female gonad development (GO:0008585) | 2.52150006 |
| 162 | tRNA aminoacylation for protein translation (GO:0006418) | 2.52090112 |
| 163 | nuclear pore complex assembly (GO:0051292) | 2.51776560 |
| 164 | kinetochore assembly (GO:0051382) | 2.51546814 |
| 165 | regulation of chromosome segregation (GO:0051983) | 2.48569473 |
| 166 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.47014698 |
| 167 | regulation of gene silencing by miRNA (GO:0060964) | 2.47014698 |
| 168 | regulation of gene silencing by RNA (GO:0060966) | 2.47014698 |
| 169 | mitotic spindle assembly checkpoint (GO:0007094) | 2.46793749 |
| 170 | amino acid activation (GO:0043038) | 2.45738977 |
| 171 | tRNA aminoacylation (GO:0043039) | 2.45738977 |
| 172 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.45670942 |
| 173 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.45611464 |
| 174 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.45611464 |
| 175 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.44882362 |
| 176 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.44882362 |
| 177 | regulation of sister chromatid segregation (GO:0033045) | 2.44882362 |
| 178 | DNA strand renaturation (GO:0000733) | 2.44437185 |
| 179 | ATP-dependent chromatin remodeling (GO:0043044) | 2.44220771 |
| 180 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.41356298 |
| 181 | spindle assembly checkpoint (GO:0071173) | 2.40381025 |
| 182 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.38356961 |
| 183 | sterol biosynthetic process (GO:0016126) | 2.38012143 |
| 184 | nuclear pore organization (GO:0006999) | 2.37441809 |
| 185 | notochord development (GO:0030903) | 2.37287873 |
| 186 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.36178458 |
| 187 | protein deneddylation (GO:0000338) | 2.35510516 |
| 188 | regulation of cell fate specification (GO:0042659) | 2.34956041 |
| 189 | telomere maintenance via recombination (GO:0000722) | 2.34771907 |
| 190 | negative regulation of mitosis (GO:0045839) | 2.34396278 |
| 191 | protein neddylation (GO:0045116) | 2.31841779 |
| 192 | response to X-ray (GO:0010165) | 2.31649665 |
| 193 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.30257528 |
| 194 | establishment of chromosome localization (GO:0051303) | 2.30111634 |
| 195 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.28753091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.86707146 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.20357863 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.94131130 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.56203148 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.30292236 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.11591322 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74147127 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67084611 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51885703 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.16579668 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.15813539 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.93649836 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.80724382 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64230912 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.62184378 |
| 16 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.27944367 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24904230 |
| 18 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.20591170 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.20508496 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.20337191 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.14663008 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14496452 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06014015 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99357564 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.99342188 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.95816653 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92492272 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92114450 |
| 29 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.91769736 |
| 30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.89640002 |
| 31 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.88023384 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.85382190 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.83737406 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82556556 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.79168492 |
| 36 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77883271 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.75409813 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74394704 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.72351377 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64666849 |
| 41 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.61797896 |
| 42 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57735632 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57062793 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56889620 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.55446531 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.55269750 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53133066 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51921807 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.50441004 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48963657 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47805823 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46648755 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.45682013 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41574515 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36228042 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35524592 |
| 57 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35153893 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33761979 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32364155 |
| 60 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.31959246 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31310166 |
| 62 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.31122398 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30364933 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28967061 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.26904471 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25779753 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24025520 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.22435861 |
| 69 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22279011 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21320397 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20610162 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20229457 |
| 73 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.18680412 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16602798 |
| 75 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16583183 |
| 76 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15585463 |
| 77 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.15310562 |
| 78 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.11051372 |
| 79 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10965119 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10154518 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09334900 |
| 82 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08341753 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04404600 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03906431 |
| 85 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03271100 |
| 86 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03179505 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.01588830 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01389682 |
| 89 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01267686 |
| 90 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00646309 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00047250 |
| 92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00047250 |
| 93 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00047250 |
| 94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99647805 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99118551 |
| 96 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97908409 |
| 97 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96919109 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95178400 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94855946 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.93856346 |
| 101 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93295936 |
| 102 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91563264 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91202145 |
| 104 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.90718051 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90522618 |
| 106 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90426614 |
| 107 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90128671 |
| 108 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89809126 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89622422 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89491362 |
| 111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.89356648 |
| 112 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.88438408 |
| 113 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88011807 |
| 114 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.87893347 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87841064 |
| 116 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87762731 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87738571 |
| 118 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87630506 |
| 119 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.87548875 |
| 120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87283157 |
| 121 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86799697 |
| 122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85594130 |
| 123 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.84997449 |
| 124 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.82815295 |
| 125 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.82466539 |
| 126 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82190009 |
| 127 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.81068610 |
| 128 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80908675 |
| 129 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.79983900 |
| 130 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.78871640 |
| 131 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78687637 |
| 132 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.75691575 |
| 133 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.75213237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.38494181 |
| 2 | MP0005360_urolithiasis | 6.82615911 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 5.98271583 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.72311583 |
| 5 | MP0005365_abnormal_bile_salt | 5.31724632 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.55295011 |
| 7 | MP0003941_abnormal_skin_development | 3.58016323 |
| 8 | MP0003252_abnormal_bile_duct | 3.26092768 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.88471411 |
| 10 | MP0009840_abnormal_foam_cell | 2.83244275 |
| 11 | MP0005332_abnormal_amino_acid | 2.72624535 |
| 12 | MP0003195_calcinosis | 2.41453582 |
| 13 | MP0005083_abnormal_biliary_tract | 2.37468795 |
| 14 | MP0004272_abnormal_basement_membrane | 2.37221562 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.33053993 |
| 16 | MP0003186_abnormal_redox_activity | 2.28715989 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.26460112 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.13645872 |
| 19 | MP0003122_maternal_imprinting | 2.04608405 |
| 20 | MP0009697_abnormal_copulation | 2.04178922 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.03068635 |
| 22 | MP0003937_abnormal_limbs/digits/tail_de | 1.99527179 |
| 23 | MP0002938_white_spotting | 1.88954090 |
| 24 | MP0000609_abnormal_liver_physiology | 1.82091335 |
| 25 | MP0003011_delayed_dark_adaptation | 1.81398188 |
| 26 | MP0001299_abnormal_eye_distance/ | 1.79341159 |
| 27 | MP0002233_abnormal_nose_morphology | 1.75278948 |
| 28 | MP0001764_abnormal_homeostasis | 1.74376034 |
| 29 | MP0006054_spinal_hemorrhage | 1.74172859 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.73617528 |
| 31 | MP0005451_abnormal_body_composition | 1.71939502 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.66405611 |
| 33 | MP0003718_maternal_effect | 1.62028922 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.59953254 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.51570290 |
| 36 | MP0003868_abnormal_feces_composition | 1.51313968 |
| 37 | MP0005408_hypopigmentation | 1.47602318 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.45153328 |
| 39 | MP0000049_abnormal_middle_ear | 1.42702323 |
| 40 | MP0001529_abnormal_vocalization | 1.41818957 |
| 41 | MP0002084_abnormal_developmental_patter | 1.38925201 |
| 42 | MP0003121_genomic_imprinting | 1.38100025 |
| 43 | MP0005499_abnormal_olfactory_system | 1.35682573 |
| 44 | MP0005394_taste/olfaction_phenotype | 1.35682573 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.35574202 |
| 46 | MP0002085_abnormal_embryonic_tissue | 1.33659243 |
| 47 | MP0000428_abnormal_craniofacial_morphol | 1.32921950 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.31342693 |
| 49 | MP0003755_abnormal_palate_morphology | 1.30827210 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.30339434 |
| 51 | MP0003385_abnormal_body_wall | 1.29568225 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29480754 |
| 53 | MP0004957_abnormal_blastocyst_morpholog | 1.27816496 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.27008415 |
| 55 | MP0003942_abnormal_urinary_system | 1.26891078 |
| 56 | MP0005275_abnormal_skin_tensile | 1.24017097 |
| 57 | MP0000598_abnormal_liver_morphology | 1.22552569 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.22239801 |
| 59 | MP0000762_abnormal_tongue_morphology | 1.18794228 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.17544181 |
| 61 | MP0002234_abnormal_pharynx_morphology | 1.14671684 |
| 62 | MP0002751_abnormal_autonomic_nervous | 1.13177036 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.13047179 |
| 64 | MP0002102_abnormal_ear_morphology | 1.10758906 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.08866966 |
| 66 | MP0009053_abnormal_anal_canal | 1.08471363 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.03302678 |
| 68 | MP0003136_yellow_coat_color | 1.02941914 |
| 69 | MP0005647_abnormal_sex_gland | 0.99939214 |
| 70 | MP0009703_decreased_birth_body | 0.99684605 |
| 71 | MP0009250_abnormal_appendicular_skeleto | 0.98814367 |
| 72 | * MP0005266_abnormal_metabolism | 0.98138117 |
| 73 | MP0000432_abnormal_head_morphology | 0.98103532 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 0.97317375 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.95979284 |
| 76 | MP0003077_abnormal_cell_cycle | 0.93660919 |
| 77 | MP0000537_abnormal_urethra_morphology | 0.93478437 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 0.93051123 |
| 79 | MP0003935_abnormal_craniofacial_develop | 0.91745463 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.91632621 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.91512001 |
| 82 | MP0003123_paternal_imprinting | 0.91005234 |
| 83 | MP0003283_abnormal_digestive_organ | 0.90291170 |
| 84 | * MP0009763_increased_sensitivity_to | 0.90179654 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.89793154 |
| 86 | MP0002282_abnormal_trachea_morphology | 0.88891466 |
| 87 | MP0005395_other_phenotype | 0.88555317 |
| 88 | * MP0005376_homeostasis/metabolism_phenot | 0.88008845 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.87583749 |
| 90 | MP0001177_atelectasis | 0.87290838 |
| 91 | MP0003861_abnormal_nervous_system | 0.85103252 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.83872667 |
| 93 | MP0009379_abnormal_foot_pigmentation | 0.83510868 |
| 94 | MP0004133_heterotaxia | 0.82294206 |
| 95 | MP0005391_vision/eye_phenotype | 0.81909111 |
| 96 | MP0000579_abnormal_nail_morphology | 0.81290107 |
| 97 | MP0001984_abnormal_olfaction | 0.79777344 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.78698851 |
| 99 | MP0001849_ear_inflammation | 0.76785166 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.75761435 |
| 101 | MP0002116_abnormal_craniofacial_bone | 0.74277705 |
| 102 | MP0005670_abnormal_white_adipose | 0.74207791 |
| 103 | MP0003890_abnormal_embryonic-extraembry | 0.73831374 |
| 104 | MP0003111_abnormal_nucleus_morphology | 0.73187057 |
| 105 | MP0008932_abnormal_embryonic_tissue | 0.73147765 |
| 106 | MP0008057_abnormal_DNA_replication | 0.72617530 |
| 107 | MP0008058_abnormal_DNA_repair | 0.72380847 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.72148919 |
| 109 | MP0001730_embryonic_growth_arrest | 0.72039713 |
| 110 | MP0005508_abnormal_skeleton_morphology | 0.71670319 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.70955330 |
| 112 | MP0002132_abnormal_respiratory_system | 0.70921793 |
| 113 | MP0002090_abnormal_vision | 0.70671466 |
| 114 | MP0002295_abnormal_pulmonary_circulatio | 0.70503202 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.69577056 |
| 116 | MP0003115_abnormal_respiratory_system | 0.68746753 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.66276961 |
| 118 | * MP0009765_abnormal_xenobiotic_induced | 0.65059348 |
| 119 | MP0009672_abnormal_birth_weight | 0.64963460 |
| 120 | MP0001661_extended_life_span | 0.64344807 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.63435833 |
| 122 | MP0008469_abnormal_protein_level | 0.62652370 |
| 123 | MP0001756_abnormal_urination | 0.61657493 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.59790095 |
| 125 | MP0000566_synostosis | 0.58391505 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.55042996 |
| 127 | MP0001915_intracranial_hemorrhage | 0.54934385 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.54827998 |
| 129 | MP0009764_decreased_sensitivity_to | 0.52500031 |
| 130 | MP0002249_abnormal_larynx_morphology | 0.51706126 |
| 131 | * MP0008873_increased_physiological_sensi | 0.45814556 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.45721087 |
| 133 | MP0001119_abnormal_female_reproductive | 0.44138642 |
| 134 | MP0001293_anophthalmia | 0.43126603 |
| 135 | MP0003567_abnormal_fetal_cardiomyocyte | 0.42588522 |
| 136 | MP0001672_abnormal_embryogenesis/_devel | 0.42578176 |
| 137 | MP0005380_embryogenesis_phenotype | 0.42578176 |
| 138 | MP0005023_abnormal_wound_healing | 0.42411080 |
| 139 | MP0000604_amyloidosis | 0.41380919 |
| 140 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41262444 |
| 141 | MP0002111_abnormal_tail_morphology | 0.41073386 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.40674990 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.40255003 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.38822893 |
| 145 | MP0001697_abnormal_embryo_size | 0.38303472 |
| 146 | MP0003119_abnormal_digestive_system | 0.38299608 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.37601468 |
| 148 | MP0002254_reproductive_system_inflammat | 0.37574813 |
| 149 | MP0000350_abnormal_cell_proliferation | 0.37433476 |
| 150 | MP0003699_abnormal_female_reproductive | 0.37109975 |
| 151 | MP0001286_abnormal_eye_development | 0.37045844 |
| 152 | MP0002092_abnormal_eye_morphology | 0.36893274 |
| 153 | MP0002080_prenatal_lethality | 0.36106297 |
| 154 | MP0004197_abnormal_fetal_growth/weight/ | 0.35358323 |
| 155 | MP0005248_abnormal_Harderian_gland | 0.35012913 |
| 156 | MP0000358_abnormal_cell_content/ | 0.34919411 |
| 157 | MP0002697_abnormal_eye_size | 0.34684757 |
| 158 | MP0002088_abnormal_embryonic_growth/wei | 0.34264680 |
| 159 | MP0003984_embryonic_growth_retardation | 0.34029303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.65497421 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.64996459 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.28863193 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.24358668 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.96148617 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.23968322 |
| 7 | Xanthomatosis (HP:0000991) | 4.96307934 |
| 8 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.59532406 |
| 9 | Hyperglycinemia (HP:0002154) | 4.56692834 |
| 10 | Hyperammonemia (HP:0001987) | 4.54823547 |
| 11 | Abnormality of methionine metabolism (HP:0010901) | 4.44047423 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.39894841 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.30632423 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.28934552 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.28934552 |
| 16 | Hyperglycinuria (HP:0003108) | 4.28846874 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.20904761 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.15046545 |
| 19 | Complement deficiency (HP:0004431) | 4.11709116 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89837289 |
| 21 | Ketosis (HP:0001946) | 3.76445687 |
| 22 | Epidermoid cyst (HP:0200040) | 3.67911398 |
| 23 | Fat malabsorption (HP:0002630) | 3.66934852 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65482007 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61440359 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.54185021 |
| 27 | Joint hemorrhage (HP:0005261) | 3.50235237 |
| 28 | Abnormality of the labia minora (HP:0012880) | 3.47975278 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46891657 |
| 30 | Abnormality of serum amino acid levels (HP:0003112) | 3.40897367 |
| 31 | Delayed CNS myelination (HP:0002188) | 3.36158192 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.29414750 |
| 33 | Cerebral edema (HP:0002181) | 3.24817609 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.24027693 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.20033448 |
| 36 | Colon cancer (HP:0003003) | 3.14446144 |
| 37 | Lethargy (HP:0001254) | 3.10917784 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.00118577 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98219608 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 2.97330140 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97330140 |
| 42 | Abnormality of complement system (HP:0005339) | 2.97202219 |
| 43 | Steatorrhea (HP:0002570) | 2.95735091 |
| 44 | Abnormality of glycolysis (HP:0004366) | 2.95411185 |
| 45 | Increased serum pyruvate (HP:0003542) | 2.95411185 |
| 46 | Spastic diplegia (HP:0001264) | 2.85031831 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.84089489 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80927346 |
| 49 | Metabolic acidosis (HP:0001942) | 2.75805838 |
| 50 | Septo-optic dysplasia (HP:0100842) | 2.71113158 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.68361027 |
| 52 | Meckel diverticulum (HP:0002245) | 2.67804656 |
| 53 | Abnormal lung lobation (HP:0002101) | 2.67284025 |
| 54 | Hepatoblastoma (HP:0002884) | 2.64634771 |
| 55 | Ketoacidosis (HP:0001993) | 2.58866883 |
| 56 | Birth length less than 3rd percentile (HP:0003561) | 2.53622290 |
| 57 | Abnormality of the ileum (HP:0001549) | 2.49851558 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.46823059 |
| 59 | Bifid tongue (HP:0010297) | 2.46369456 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.35112514 |
| 61 | Opisthotonus (HP:0002179) | 2.29160610 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.29074485 |
| 63 | Vascular calcification (HP:0004934) | 2.29074361 |
| 64 | Spontaneous abortion (HP:0005268) | 2.28377084 |
| 65 | Acute encephalopathy (HP:0006846) | 2.27965986 |
| 66 | Chromsome breakage (HP:0040012) | 2.26502046 |
| 67 | Vomiting (HP:0002013) | 2.26211065 |
| 68 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.26034265 |
| 69 | Cortical dysplasia (HP:0002539) | 2.25707710 |
| 70 | Glycosuria (HP:0003076) | 2.24065035 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.24065035 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23042854 |
| 73 | Hepatic necrosis (HP:0002605) | 2.22021055 |
| 74 | Irritability (HP:0000737) | 2.19602428 |
| 75 | Brushfield spots (HP:0001088) | 2.18404447 |
| 76 | Embryonal renal neoplasm (HP:0011794) | 2.17589558 |
| 77 | Malnutrition (HP:0004395) | 2.17574605 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.17563209 |
| 79 | Alkalosis (HP:0001948) | 2.15207246 |
| 80 | Nausea (HP:0002018) | 2.13919427 |
| 81 | Oral leukoplakia (HP:0002745) | 2.13811054 |
| 82 | Proximal tubulopathy (HP:0000114) | 2.13481437 |
| 83 | Abnormal cartilage morphology (HP:0002763) | 2.08249774 |
| 84 | Hypoplastic pelvis (HP:0008839) | 2.08034070 |
| 85 | Coronal craniosynostosis (HP:0004440) | 2.05783152 |
| 86 | Cholecystitis (HP:0001082) | 2.04052130 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.04052130 |
| 88 | Skin nodule (HP:0200036) | 2.02902001 |
| 89 | Enlarged kidneys (HP:0000105) | 2.02326944 |
| 90 | Supernumerary spleens (HP:0009799) | 1.98749877 |
| 91 | Neonatal onset (HP:0003623) | 1.98248122 |
| 92 | Gout (HP:0001997) | 1.97159159 |
| 93 | Renal cortical cysts (HP:0000803) | 1.95986297 |
| 94 | Cardiovascular calcification (HP:0011915) | 1.95658078 |
| 95 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.94872174 |
| 96 | Hypoglycemic seizures (HP:0002173) | 1.94574123 |
| 97 | Megaloblastic anemia (HP:0001889) | 1.94410922 |
| 98 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92759240 |
| 99 | Choanal stenosis (HP:0000452) | 1.92065123 |
| 100 | Microglossia (HP:0000171) | 1.91528843 |
| 101 | Esophageal varix (HP:0002040) | 1.89498826 |
| 102 | Abnormality of chromosome stability (HP:0003220) | 1.89224437 |
| 103 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88910695 |
| 104 | Spastic paraparesis (HP:0002313) | 1.88447987 |
| 105 | Soft skin (HP:0000977) | 1.88273278 |
| 106 | Increased nuchal translucency (HP:0010880) | 1.88271732 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 1.88268651 |
| 108 | Facial cleft (HP:0002006) | 1.87163914 |
| 109 | Protrusio acetabuli (HP:0003179) | 1.84571241 |
| 110 | Ankle contracture (HP:0006466) | 1.84548571 |
| 111 | Ependymoma (HP:0002888) | 1.84467411 |
| 112 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.84374287 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.81792550 |
| 114 | Stenosis of the external auditory canal (HP:0000402) | 1.81036791 |
| 115 | Rickets (HP:0002748) | 1.80612955 |
| 116 | Cholelithiasis (HP:0001081) | 1.80608298 |
| 117 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.80576878 |
| 118 | Triphalangeal thumb (HP:0001199) | 1.80352442 |
| 119 | Intestinal atresia (HP:0011100) | 1.80259259 |
| 120 | Elevated hepatic transaminases (HP:0002910) | 1.79624914 |
| 121 | Neoplasm of the colon (HP:0100273) | 1.78113000 |
| 122 | Abnormality of the duodenum (HP:0002246) | 1.77946846 |
| 123 | Increased muscle lipid content (HP:0009058) | 1.76842640 |
| 124 | Late onset (HP:0003584) | 1.76622917 |
| 125 | Pancreatitis (HP:0001733) | 1.75557317 |
| 126 | Systemic lupus erythematosus (HP:0002725) | 1.74640496 |
| 127 | Increased serum lactate (HP:0002151) | 1.74536148 |
| 128 | Multiple enchondromatosis (HP:0005701) | 1.73981604 |
| 129 | Duodenal stenosis (HP:0100867) | 1.73310500 |
| 130 | Small intestinal stenosis (HP:0012848) | 1.73310500 |
| 131 | Acute necrotizing encephalopathy (HP:0006965) | 1.72622566 |
| 132 | Breast aplasia (HP:0100783) | 1.70971116 |
| 133 | Lactic acidosis (HP:0003128) | 1.70961987 |
| 134 | Abnormality of dentin (HP:0010299) | 1.69002083 |
| 135 | Reticulocytopenia (HP:0001896) | 1.68734655 |
| 136 | Anophthalmia (HP:0000528) | 1.67608535 |
| 137 | Hepatocellular necrosis (HP:0001404) | 1.67328637 |
| 138 | Myocardial infarction (HP:0001658) | 1.66159028 |
| 139 | Methylmalonic aciduria (HP:0012120) | 1.65971547 |
| 140 | CNS demyelination (HP:0007305) | 1.65851297 |
| 141 | Absent septum pellucidum (HP:0001331) | 1.65700256 |
| 142 | Renal Fanconi syndrome (HP:0001994) | 1.65643614 |
| 143 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65251284 |
| 144 | Acanthocytosis (HP:0001927) | 1.63892565 |
| 145 | Hypoplastic female external genitalia (HP:0012815) | 1.63843593 |
| 146 | Neoplasm of the adrenal gland (HP:0100631) | 1.63458417 |
| 147 | Increased hepatocellular lipid droplets (HP:0006565) | 1.63285816 |
| 148 | Methylmalonic acidemia (HP:0002912) | 1.61334640 |
| 149 | Broad foot (HP:0001769) | 1.60710422 |
| 150 | Myelomeningocele (HP:0002475) | 1.60175110 |
| 151 | Bilateral microphthalmos (HP:0007633) | 1.59196648 |
| 152 | Abnormality of the preputium (HP:0100587) | 1.58545157 |
| 153 | Rhabdomyosarcoma (HP:0002859) | 1.56637428 |
| 154 | Neonatal short-limb short stature (HP:0008921) | 1.54715182 |
| 155 | Scrotal hypoplasia (HP:0000046) | 1.52899940 |
| 156 | Medulloblastoma (HP:0002885) | 1.52274295 |
| 157 | Breast hypoplasia (HP:0003187) | 1.50982402 |
| 158 | Partial duplication of the phalanx of hand (HP:0009999) | 1.46994045 |
| 159 | Preaxial foot polydactyly (HP:0001841) | 1.46546912 |
| 160 | Partial duplication of thumb phalanx (HP:0009944) | 1.46417645 |
| 161 | Abnormality of the septum pellucidum (HP:0007375) | 1.45290855 |
| 162 | Labial hypoplasia (HP:0000066) | 1.45246297 |
| 163 | Pterygium (HP:0001059) | 1.44688255 |
| 164 | Chronic hepatic failure (HP:0100626) | 1.44077541 |
| 165 | Hemivertebrae (HP:0002937) | 1.43548071 |
| 166 | Renal hypoplasia (HP:0000089) | 1.43368265 |
| 167 | Generalized hypotonia (HP:0001290) | 1.43120904 |
| 168 | Vaginal atresia (HP:0000148) | 1.43001623 |
| 169 | Broad metatarsal (HP:0001783) | 1.42950210 |
| 170 | Biliary tract neoplasm (HP:0100574) | 1.42572650 |
| 171 | Gonadotropin excess (HP:0000837) | 1.42454621 |
| 172 | Ovarian neoplasm (HP:0100615) | 1.41768139 |
| 173 | Abnormality of the clitoris (HP:0000056) | 1.41446704 |
| 174 | Maternal diabetes (HP:0009800) | 1.40843774 |
| 175 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.40253448 |
| 176 | Macrocytic anemia (HP:0001972) | 1.39666256 |
| 177 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.39444691 |
| 178 | Genital tract atresia (HP:0001827) | 1.39315434 |
| 179 | Dental crowding (HP:0000678) | 1.38227824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.88626259 |
| 2 | BUB1 | 3.69903768 |
| 3 | EIF2AK1 | 2.76507346 |
| 4 | WEE1 | 2.64810796 |
| 5 | TESK2 | 2.56051788 |
| 6 | ERBB4 | 2.48116160 |
| 7 | CDC7 | 2.43431263 |
| 8 | PBK | 2.38880157 |
| 9 | MKNK2 | 2.34143845 |
| 10 | TLK1 | 2.23791715 |
| 11 | NME2 | 2.11335097 |
| 12 | ACVR1B | 2.11156665 |
| 13 | TRIM28 | 2.08807252 |
| 14 | TTK | 1.99231358 |
| 15 | TNIK | 1.92518967 |
| 16 | VRK2 | 1.89821864 |
| 17 | STK38L | 1.88788231 |
| 18 | STK16 | 1.81274346 |
| 19 | SRPK1 | 1.76022795 |
| 20 | FGFR4 | 1.73635767 |
| 21 | NEK1 | 1.69440288 |
| 22 | FLT3 | 1.65663371 |
| 23 | KDR | 1.64697749 |
| 24 | EIF2AK3 | 1.54343671 |
| 25 | TAF1 | 1.51281044 |
| 26 | PLK4 | 1.44773847 |
| 27 | ABL2 | 1.41692416 |
| 28 | VRK1 | 1.39701711 |
| 29 | SIK1 | 1.36100023 |
| 30 | NEK9 | 1.34849757 |
| 31 | LATS1 | 1.32920043 |
| 32 | BMPR1B | 1.31863277 |
| 33 | RPS6KB2 | 1.30272274 |
| 34 | PLK1 | 1.29499831 |
| 35 | TGFBR1 | 1.24733095 |
| 36 | EPHA2 | 1.22699286 |
| 37 | CDK7 | 1.21059521 |
| 38 | PDK2 | 1.19597911 |
| 39 | DYRK2 | 1.18513422 |
| 40 | PLK2 | 1.16751075 |
| 41 | MET | 1.15478500 |
| 42 | MAPK11 | 1.14225053 |
| 43 | FGFR1 | 1.12840187 |
| 44 | MAP3K8 | 1.12450736 |
| 45 | AURKA | 1.12131277 |
| 46 | AURKB | 1.10982618 |
| 47 | DYRK3 | 1.09707282 |
| 48 | PASK | 1.07244903 |
| 49 | CSNK1G3 | 1.06198011 |
| 50 | ERN1 | 1.04705562 |
| 51 | NME1 | 1.04235353 |
| 52 | CASK | 1.04088763 |
| 53 | PDGFRA | 1.03434055 |
| 54 | BRSK1 | 1.00413859 |
| 55 | MAP3K11 | 0.95754830 |
| 56 | CSNK1G1 | 0.94957264 |
| 57 | CDK4 | 0.94230039 |
| 58 | ERBB3 | 0.89841966 |
| 59 | TSSK6 | 0.89387985 |
| 60 | MAP2K3 | 0.87077677 |
| 61 | PLK3 | 0.86391604 |
| 62 | PAK4 | 0.85655758 |
| 63 | NEK2 | 0.85474746 |
| 64 | PNCK | 0.83644768 |
| 65 | TAOK2 | 0.83554210 |
| 66 | FGFR2 | 0.81550208 |
| 67 | BRSK2 | 0.80267972 |
| 68 | ATR | 0.80008987 |
| 69 | STK10 | 0.79159951 |
| 70 | MELK | 0.78198815 |
| 71 | STK3 | 0.76055242 |
| 72 | PIK3CG | 0.75592774 |
| 73 | MKNK1 | 0.73922167 |
| 74 | CHEK2 | 0.72128700 |
| 75 | CDK6 | 0.71789069 |
| 76 | CSNK2A2 | 0.71708253 |
| 77 | MST4 | 0.71238708 |
| 78 | BRAF | 0.71134201 |
| 79 | ALK | 0.70517296 |
| 80 | CSNK2A1 | 0.70364952 |
| 81 | BCR | 0.70123237 |
| 82 | WNK3 | 0.68449924 |
| 83 | MAP3K3 | 0.67648900 |
| 84 | STK4 | 0.66628966 |
| 85 | MAP4K2 | 0.65480822 |
| 86 | EPHA4 | 0.64625309 |
| 87 | CDK19 | 0.64029466 |
| 88 | MAP3K12 | 0.60594334 |
| 89 | MAP2K2 | 0.60519344 |
| 90 | PKN2 | 0.60367021 |
| 91 | CSNK1A1L | 0.60170301 |
| 92 | PAK2 | 0.59879291 |
| 93 | ERBB2 | 0.59791058 |
| 94 | DDR2 | 0.58247236 |
| 95 | LATS2 | 0.56689146 |
| 96 | MAP2K6 | 0.55802031 |
| 97 | EIF2AK2 | 0.55015994 |
| 98 | TYK2 | 0.53578220 |
| 99 | CHEK1 | 0.52778357 |
| 100 | MAP3K4 | 0.51892973 |
| 101 | MAP3K10 | 0.51228730 |
| 102 | LIMK1 | 0.50403747 |
| 103 | DMPK | 0.48654932 |
| 104 | RPS6KA4 | 0.48602526 |
| 105 | STK39 | 0.48427396 |
| 106 | MST1R | 0.47817064 |
| 107 | GRK6 | 0.46975876 |
| 108 | TIE1 | 0.46453606 |
| 109 | OXSR1 | 0.44212289 |
| 110 | NLK | 0.42554809 |
| 111 | CDK18 | 0.42534194 |
| 112 | ZAK | 0.42301161 |
| 113 | MYLK | 0.41658931 |
| 114 | CSNK1G2 | 0.41598758 |
| 115 | MAP3K6 | 0.41251589 |
| 116 | PRKDC | 0.40776842 |
| 117 | PIM1 | 0.40567988 |
| 118 | CDK1 | 0.38606305 |
| 119 | NUAK1 | 0.38590278 |
| 120 | LRRK2 | 0.38522184 |
| 121 | CDK3 | 0.37683665 |
| 122 | NTRK1 | 0.37635633 |
| 123 | ROCK2 | 0.37468442 |
| 124 | CDK15 | 0.36907545 |
| 125 | CDK14 | 0.36873491 |
| 126 | MAPK4 | 0.36800867 |
| 127 | PAK1 | 0.36422382 |
| 128 | RPS6KA5 | 0.36345390 |
| 129 | PRKCE | 0.36232591 |
| 130 | CDK11A | 0.35052803 |
| 131 | ATM | 0.34245892 |
| 132 | MINK1 | 0.34134145 |
| 133 | PTK2 | 0.33648083 |
| 134 | CDK8 | 0.32942848 |
| 135 | GSK3A | 0.32752895 |
| 136 | CSNK1E | 0.32475232 |
| 137 | PRKCG | 0.32357261 |
| 138 | BRD4 | 0.32316174 |
| 139 | CDK2 | 0.32227214 |
| 140 | PRKCI | 0.31129921 |
| 141 | EPHB2 | 0.30848100 |
| 142 | TAOK3 | 0.29927380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.64667588 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.97093960 |
| 3 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.76913947 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70404047 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68264489 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55734289 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39440205 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38285703 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.37813692 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27414925 |
| 11 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.17247578 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.06808991 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05570402 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.97597367 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96166950 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96005538 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95775962 |
| 18 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93504804 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.88722535 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.88064560 |
| 21 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76502628 |
| 22 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75290891 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74026417 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72713874 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68865669 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67994458 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64476911 |
| 28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.63318092 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62582595 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60039823 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59251994 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59251796 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58821131 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57378133 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56837870 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49245941 |
| 37 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.43484302 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.42179796 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42025110 |
| 40 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.40442845 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36232393 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34968644 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34825907 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30171574 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28106387 |
| 46 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27865265 |
| 47 | DNA replication_Homo sapiens_hsa03030 | 1.23057089 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15403546 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14182583 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.12089389 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11447975 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09601853 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 1.06540227 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06106601 |
| 55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.98422271 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95880608 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94962949 |
| 58 | Ribosome_Homo sapiens_hsa03010 | 0.94654754 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92282107 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.86301243 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85904144 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85890901 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85699790 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85432169 |
| 65 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84361830 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83361508 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83350443 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.81043807 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77354221 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72382943 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71865752 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.71076008 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.70311598 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70058968 |
| 75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.68238055 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67023220 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.66942369 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66757906 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.65693904 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.62661404 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60251005 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59462299 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59045240 |
| 84 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58790188 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58170878 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58139422 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57569341 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.55555593 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.53970483 |
| 90 | Spliceosome_Homo sapiens_hsa03040 | 0.52879552 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.50603636 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49950324 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49108777 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47099874 |
| 95 | RNA transport_Homo sapiens_hsa03013 | 0.44339250 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44230211 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44143644 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40592045 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40545999 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39842070 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38634911 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36166061 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33947854 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31125447 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27600028 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26880173 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.26252857 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24678079 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24581488 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.24197840 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22483597 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.22028038 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | 0.21360153 |
| 114 | Protein export_Homo sapiens_hsa03060 | 0.18907101 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.18836761 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18225319 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.16488530 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15451775 |

